[go: up one dir, main page]

WO2006014518A3 - Activation de la cicatrisation - Google Patents

Activation de la cicatrisation Download PDF

Info

Publication number
WO2006014518A3
WO2006014518A3 PCT/US2005/024045 US2005024045W WO2006014518A3 WO 2006014518 A3 WO2006014518 A3 WO 2006014518A3 US 2005024045 W US2005024045 W US 2005024045W WO 2006014518 A3 WO2006014518 A3 WO 2006014518A3
Authority
WO
WIPO (PCT)
Prior art keywords
wound healing
promotion
antitrypsin
sequential
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/024045
Other languages
English (en)
Other versions
WO2006014518A2 (fr
Inventor
Alicia Essler
Lorraine Nisbet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts Amherst
Original Assignee
University of Massachusetts Amherst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0418664A external-priority patent/GB2415903A/en
Application filed by University of Massachusetts Amherst filed Critical University of Massachusetts Amherst
Publication of WO2006014518A2 publication Critical patent/WO2006014518A2/fr
Publication of WO2006014518A3 publication Critical patent/WO2006014518A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des combinaisons formées d'un inhibiteur de l'élastase, tel qu'une alpha-1-antitrypsine, et d'un ou plusieurs facteurs de croissance, destinées à être administrées de façon simultanée, séquentielle ou séparée, pour activer la cicatrisation.
PCT/US2005/024045 2004-07-07 2005-07-07 Activation de la cicatrisation Ceased WO2006014518A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58605304P 2004-07-07 2004-07-07
US60/586,053 2004-07-07
GB0418664A GB2415903A (en) 2004-07-07 2004-08-20 Pharmaceutical preparation which promotes wound healing
GB0418664.9 2004-08-20

Publications (2)

Publication Number Publication Date
WO2006014518A2 WO2006014518A2 (fr) 2006-02-09
WO2006014518A3 true WO2006014518A3 (fr) 2006-05-18

Family

ID=35787636

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/024045 Ceased WO2006014518A2 (fr) 2004-07-07 2005-07-07 Activation de la cicatrisation

Country Status (1)

Country Link
WO (1) WO2006014518A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108524543A (zh) * 2018-07-12 2018-09-14 济南磐升生物技术有限公司 人弹性蛋白酶抑制剂在皮肤创伤愈合中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012693A1 (en) * 2000-02-29 2002-01-31 Cohen Kelman I. Wound dressings with protease-lowering activity
US6638909B1 (en) * 1996-11-01 2003-10-28 Ethicon, Inc. Wound healing compositions containing alpha-1-antitrypsin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638909B1 (en) * 1996-11-01 2003-10-28 Ethicon, Inc. Wound healing compositions containing alpha-1-antitrypsin
US20020012693A1 (en) * 2000-02-29 2002-01-31 Cohen Kelman I. Wound dressings with protease-lowering activity

Also Published As

Publication number Publication date
WO2006014518A2 (fr) 2006-02-09

Similar Documents

Publication Publication Date Title
WO2008060622A3 (fr) Méthodes et compositions améliorées pour la cicatrisation des plaies
USD629114S1 (en) Set of bandages for a healing wound
WO2006020994A3 (fr) Compositions et methodes utilisant de l'acide hyaluronique
WO2011046964A3 (fr) Inhibiteurs de tyrosine kinase de bruton
WO2007106537A3 (fr) Aminoquinolones utilisées comme inhibiteurs de la gsk-3
WO2009154840A3 (fr) Compositions et méthodes utilisant des cellules souches dans la cicatrisation de plaies cutanées
WO2006037981A8 (fr) Inhibition de la migration de cellules tumorales
IL181327A0 (en) Wound dressing compositions, especially for delivery of protease inhibitors
WO2006138468A3 (fr) Guerison de blessure
AU2006226897B2 (en) Combinations for the treatment of cancer comprising anti-EGFR antibody and VEGFR inhibitors
WO2007061939A3 (fr) Dérivés de métabolites de l'inhibiteur de hdac fk228
EP2540301A3 (fr) Procédés et compositions pharmaceutiques servant à guérir des blessures
WO2006024640A3 (fr) Triazolophtalazines
WO2007133944A3 (fr) Administration topique d'acyclovir
WO2004108062A3 (fr) Prophylaxie et/ou therapie de l'hypertonie portale
WO2005001039A3 (fr) Production de petits arn interferents (arnsi) regulee par les ribozymes et procedes d'utilisation de ceux-ci
WO2006034035A3 (fr) Traitement de l'ischemie
WO2006036817A3 (fr) Variants fongiques et utilisations correspondantes
WO2008066729A3 (fr) Compositions contenant de l'acide boronique
WO2006029398A3 (fr) Tout-trans-retinol:tout-trans-13,14-dihydroretinol saturase et procedes d'utilisation de cette enzyme
WO2006014518A3 (fr) Activation de la cicatrisation
SE0301883D0 (sv) New use II
WO2006023562A3 (fr) 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidine-2, 4-dione et ses analogues utilises en tant qu'inhibiteurs de l'elastase du macrophage
WO2006007254A3 (fr) Biomarqueurs destines a soigner des blessures
NO20071330L (no) Enzyminhibitor i leukemi

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase